Evolución e impacto presupuestario de posibles mejoras en el Programa de Inmunizaciones: Uruguay 2007-2017

Abstract

Introduction: national vaccination programmes present a comprehensive approach that aims to reduce or suppress the consequences of immunopreventable diseases. The aim of the study was to evaluate the progress of the National Vaccination Plan (NVP) in Uruguay, its expenditure and to estimate the budgetary impact of using the quadrivalent influenza vaccine (QIV) to replace the trivalent influenza vaccine (TIV). Material and methods: the evolution of Uruguay’s NVP 2007-2017 was assessed. A current scenario (TIV) and an alternative scenario (QIV) were defined. The results were expressed as the total budgetary impact, relative to the QIV scenario versus TIV in 2017. Results: in the period, Uruguay increased its NVP expenditure 3.4 times. Spending on vaccines per person-year in Uruguay reached 2.56 million USD. The modification in the QIV vaccination schedule could generate an increase of 12% (1 million USD) in the 2017 budget. Conclusions: first budget impact analysis study to be conducted in Uruguay with the objective of estimating the budgetary impact in this case of the transition from TIV to QIV. These results are essential to support local and regional health systems in their decision-making related to vaccination.